Concert Pharmaceuticals Announces Promising Phase 1 Trial Data on Modified Version of CF Treatment Ivacaftor
Cystic Fibrosis, News
Promising clinical data from a Phase 1 multiple ascending trial of a deuterium-modified version of the commercially available Kalydeco® (ivacaftor), a drug used to treat cystic fibrosis (CF) in patients ... Read more